May 15, 2012 Corporate Council Meeting
View the presentations from the May 15, 2012 Corporate Council Meeting.
- OOPD Program Update
- Nisha Jain, MD, Chief, Clinical Review Branch DH/OBRR/CBER/FDA: CBER Rare Diseases Program - Update 2011-2012
- Markham C. Luke, MD PhD, Deputy Director for Clinical Office of Device Evaluation, CDRH, FDA: FDA Update - CDRH
- PDUFA Legislative Update
- Steven Grossman, President, HPS Group, LLC: PDUFA Reauthorization: Advancing Rare Disease and Orphan Drug Policies
- Peter L. Saltonstall, President and CEO, NORD and Yann LeCam, President and CEO, EURORDIS: NORD/EURORDIS Strategic Partnership Update